Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary

Eur J Clin Invest. 2015 Nov;45(11):1145-52. doi: 10.1111/eci.12518. Epub 2015 Sep 13.

Abstract

Background: Cancer of unknown primary (CUP) possesses distinct biology and peculiar natural history, in which the roles of the winged and hedgehog signalling pathways are unclear.

Materials and methods: We constructed tissue microarrays and studied the immunohistochemical (IHC) expression of β-catenin, smoothened (SMO) and the transcription factors TCF, LEF, GLI1 in 87 CUP cases for prognostic significance.

Results: A low rate of IHC expression of proteins was seen, the cut-off used being any expression in ≥ 1% of tumour cells. At univariate analysis, only nuclear IHC SMO expression displayed a statistically significant association with favourable outcome [median Overall survival (OS) of 19 months in SMO-positive vs. 12 months in SMO-negative cases, P = 0·01]. An activated Wnt pathway, defined as IHC expression of any of nuclear β-catenin, TCF and LEF, was significantly associated with favourable progression free survival (median 9 vs. 5 months, P = 0·037) and OS (median 19 vs. 13 months, P = 0·04). This prognostic impact on OS was mainly driven by nuclear expression of TCF and/or LEF (P = 0·03). No prognostic significance of the hedgehog pathway activation status, defined as IHC expression of SMO or nuclear GLI1, could be established. A favourable prognostic impact of the concurrent activation of both pathways was observed. A trend for association of activated Wnt with response to chemotherapy (responders 67% among activated Wnt cases vs. 35% among nonactivated Wnt cases, P = 0·07) was observed in CUP adenocarcinomas.

Conclusions: Activation of the Wnt pathway was a positive prognostic factor in a small CUP series, possibly via enhanced chemosensitivity. Independent validation is warranted.

Keywords: Cancer of unknown primary; WNT pathway; hedgehog; immunohistochemistry; prognostic; wingless.

MeSH terms

  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / mortality
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / mortality
  • Female
  • Hedgehog Proteins*
  • Humans
  • Immunohistochemistry
  • Lymphoid Enhancer-Binding Factor 1 / metabolism
  • Male
  • Middle Aged
  • Neoplasms, Unknown Primary / metabolism*
  • Neoplasms, Unknown Primary / mortality
  • Neuroendocrine Tumors / metabolism*
  • Neuroendocrine Tumors / mortality
  • Prognosis
  • Receptors, G-Protein-Coupled / metabolism
  • Retrospective Studies
  • Smoothened Receptor
  • TCF Transcription Factors / metabolism
  • Tissue Array Analysis
  • Transcription Factors / metabolism
  • Wnt Signaling Pathway*
  • Zinc Finger Protein GLI1
  • beta Catenin / metabolism

Substances

  • GLI1 protein, human
  • Hedgehog Proteins
  • Lymphoid Enhancer-Binding Factor 1
  • Receptors, G-Protein-Coupled
  • SMO protein, human
  • Smoothened Receptor
  • TCF Transcription Factors
  • Transcription Factors
  • Zinc Finger Protein GLI1
  • beta Catenin